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Bone marrow lesions (BMLs) are magnetic resonance imaging (MRI)-identified 
pathological changes in subchondral bone, closely associated with joint pain and 
osteo-chondral structural degeneration in knee osteoarthritis (KOA). Despite the 
usefulness of BMLs as diagnostic and prognostic markers in KOA, what they 
represent at the tissue level remains unclear. Thus, the thesis aim was to perform 
a comprehensive investigation of BMLs at the tissue level and their relationship 
with the structural changes in KOA. We hypothesised that BML imaged using 
MRI reflect changes in subchondral tissue of proximal tibia that related to OA 
disease severity and/or progression.  
The first study provided comprehensive tissue characterization of BMLs detected 
using two [proton density fat saturated (PDFS) and T1)] specific MRI sequences. 
Multi-modal tissue level analyses of the whole depth of the tibial osteochondral 
unit were performed. The results from tissue level analyses showed that BMLs 
detected by specific MRI sequences associate strongly with the degree of 
structural change in the osteochondral unit in KOA. Specifically, BMLs detected 
by the combination of PDFS and T1 weighted MR-sequences represent an 
advanced structural stage of OA disease, while BMLs detected only by PDFS 
weighted sequence represent less severe OA, and potentially have the ability to 
resolve. 
In the second study, potential causal factors (mechanical loading and vascular 
pathology) of BML formation were investigated by assessing the accumulation of 
microdamage, and the qualitative and quantitative aspects of blood vessels in 
BML and non-BML tissue. Increased microdamage density and increased 
 vii 
arteriolar density, with altered characteristics of vascular walls, were found in the 
zones of BML tissue, supporting the notion that both excessive and 
biomechanically unfavourable loading and vascular pathology contribute to the 
occurrence of BMLs in tibial subchondral bone tissue.  
In the third study, a potential role for components of the metabolic syndrome in 
BML development and its potential influences on the progression of KOA was 
investigated. Results from this study suggested that a combination of specific 
metabolic factors such as central obesity with BMI 30 or greater, dyslipidaemia, 
high blood pressure and high fasting glucose levels might promote the 
occurrence of BMLs in tibial subchondral bone tissue and that metabolic factors 
might contribute to the progressive osteochondral degeneration in KOA. 
The fourth study described microarchitectural changes in whole tibial plateaus 
(TP), based on the presence/absence of a BML. Tissue from healthy/control 
knees was also used to compare with that from OA with no BML and OA with 
BML, to better understand the course of OA disease and BML involvement in 
disease progression. In comparison with non-OA (control) subjects, the bone 
microstructure of the subchondral plate and trabeculae varies significantly 
between subregions of the TP in KOA. Secondly, in KOA subjects, two types of 
structural changes were identified, which were dependent on the presence or 
absence of a BML in the TP, and which related to the extent of cartilage 
degradation. Thirdly, the presence of a BML had implications for the 
microstructure of regions of the TP beyond the zone of the BML.  
In conclusion, this series of related studies demonstrates that BMLs as a feature 
of subchondral bone strongly associate with the progressive state of OA disease 
and therefore play a significant role in KOA pathogenesis. This demonstrated that 
 viii 
BMLs are valuable imaging biomarkers of KOA and that BMLs might provide 
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Chapter 1  
 
 






Osteoarthritis (OA) is a multifactorial slow-progressive disease of the whole joint. 
According to the Australian Bureau of Statistics and the Australian Institute of 
Health and Welfare, approximately 2.1 million Australians (9% of the population) 
suffered from OA in 2014–15, based on self-reported data [1]. The prevalence of 
OA is higher among females and the older population. Approximately 10% of 
females have OA compared to 6% of males. Also, it is estimated that 52% of 
people aged 75 and over suffer from this condition, compared with only 1% of 
people aged less than 25 years. The World Health Organization (WHO) estimates 
that 10% of the world’s population over 60 years of age suffers from OA, and that 
80% of people with OA experience limitation of movement and 25% cannot 
perform activities of daily living [2]. 
While OA can affect all joints in the human body, it is most common in the knee. 
The knee is the largest synovial joint in the body and it is composed of 3 bones 
(femur, tibia and patella) and 2 joints; tibio-femoral joint, which itself is comprised 
of a medial and a lateral compartment, and the patello-femoral joint (Figure 1-1) 
[3]. The proximal part of the tibia, known as the tibial plateau, is the most affected 
side of the tibio-femoral joint and suffers the most severe structural changes in 
joint disease. The current treatment options for knee OA are largely to help relieve 
the clinical symptoms. The main options are; lifestyle measures such as weight 
loss and exercises, pharmacological pain management and when those are not 
sufficient, joint replacement surgery to repair or replace damaged joints may also 
be considered. Surgical procedures restore joint function, help relieve pain and 








structural damage and clinical manifestation of symptoms, especially pain (Table 
1-1). One of the first published scoring systems was the Whole Organ Magnetic 
Resonance Imaging Score (WORMS), [20]. Since then, the Knee Osteoarthritis 
Scoring System (KOSS) [21], the Boston Leeds Osteoarthritis Knee Score 
(BLOKS) [22], and the MRI Osteoarthritis Knee Score (MOAKS) [23] have been 
developed. The reproducibility and sensitivity of these semi-quantitative systems 
have been tested in several studies [21, 22, 24]. In comparison to previous 
systems, the MOAKS exhibited very good reliability for the majority of features 
assessed, and to date it is the most recommended tool for semi-quantitative MRI 




Table 1-1. Most commonly used whole-organ scoring systems for knee 
OA 




Imaging Score) [20] 
 
Cartilage (0–6); BMLs size (0–3); subchondral cysts (0–3); bone attrition 
(0–3); effusion and synovitis (0–3); periarticular cysts (0–3); bursitides 
(0–3); loose bodies (0–3); osteophytes (0–7); meniscal tear (0-4); 
cruciate and collateral ligaments (0–1) 
 
KOSS (The Knee 
Osteoarthritis 
Scoring System) [21] 
 
Cartilage size and depth (0–3); BMLs size (0–3); subchondral cysts (0–
3); osteophytes (0–3); effusion (0–3); meniscal tear (0–3); meniscal 







Cartilage size and depth (0–3, plus extent of any cartilage loss); BMLs 
size (0–3, for each lesion); osteophytes (0–3); effusion (0–3); meniscal 
extrusion (0–3); synovitis (in Hoffa’s fat pad 0–3 and at 5 additional sites 
0–1); meniscal status (0–1 for intrameniscal signal, tears, maceration, 
meniscal cyst, each scored individually); ligaments (0–1); periarticular 






Cartilage size and depth (0–3); BMLs size (0–3, for each lesion); 
osteophytes (0–3); effusion‐synovitis (0–3); Hoffa synovitis (0–3); 
meniscal extrusion (0–3); meniscal status (0–1, for intrameniscal signal, 
tears, maceration, meniscal cyst, hypertrophy; scored individually); 
ligaments (0–1); periarticular cysts/bursitides (0–1, scored individually); 
loose bodies (0–1) 
Table 1 Adapted from “MRI based semi-quantitative scoring of joint pathology in osteoarthritis” 




The superficial zone occupies about 10% to 20% of the articular cartilage 
thickness. Inside this zone chondrocytes are arranged parallel to the articular 
surface. The reserve or transitional zone, represents 40% to 60% of the cartilage. 
In this zone collagen fibrils are arranged diagonally and the chondrocytes are 
spherical to the articular surface. The deep zone represents approximately 30% 
of articular cartilage and it is responsible for providing resistance to compressive 
forces. Collagen fibrils in this zone are arranged perpendicular to the articular 
surface and chondrocytes have a parallel orientation to the collagen. The zone of 
the calcified layer represents approximately 5% of the cartilage, and it acts as a 
transition zone from the cartilage to the bone. In this zone chondrocytes are 
hypertrophic. Healthy articular cartilage is avascular and without nerves or 
lymphatics supply.  
 
1.4.2 Subchondral bone  
Subchondral bone has been defined as the thin layer of calcified tissue, located 
immediately below the articular cartilage. It consists of two distinctive structural 
formations; the subchondral plate and subchondral trabeculae (Figure 1-8) [26, 
28, 30]. The subchondral plate is a plate-like structure located between the 
calcified cartilage at one end and subchondral trabeculae and fatty marrow 
between trabeculae at the other end [28]. Also, it has been noted by Lyons et al. 
that fingers of uncalcified cartilage, delineated by the tidemark, dip through the 
calcified cartilage into the subchondral bone and marrow spaces [31]. Thus, the 
cartilage and subchondral bone show both mechanical linkage and physical 





Figure 1-8 Micro computed tomography image (sagittal plane) of human 
proximal tibial subchondral bone indicating two distinctive structural 
formations; subchondral plate and subchondral trabeculae. 
 
The thickness of the subchondral plate varies between different joints, between 
males and females, and between different age groups, and it has been found that 
heavily loaded areas have greater thickness [26, 32]. From the subchondral plate 
arise the subchondral trabeculae, consisting of interconnected rods and plates. 
The extent of trabecular bone below the subchondral plate considered as part of 
the OCU (in the human proximal tibia) is 6-10 mm [33]. The subchondral plate 
and subchondral trabeculae are architecturally, physiologically and mechanically 
different and respond differently during OA pathogenesis [28, 34]. They undergo 
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significant changes and modifications during the development and progression 
of OA, resulting in the appearance of subchondral bone sclerosis, cysts, bone 
marrow lesions (BMLs) and/or osteophytes [34]. 
Much of the research focus in KOA has been on investigating the loss of cartilage 
cellular and structural integrity. However, a substantial amount of evidence has 
been collected showing that changes in subchondral bone have an important 
impact on the progression of KOA disease [26, 28, 35]. Animal models suggest 
that changes in the subchondral bone may even precede cartilage changes [36-
40]. Understanding changes in the subchondral bone that may alter the bone 
quality and may contribute to the joint pathogenesis of OA is essential for better 
understanding of OA aetiology and also might be important information for the 
development of effective treatments for KOA. 
 
1.5 Subchondral bone quality and osteoarthritis 
Bone quality represents the sum of all characteristics of bone that together 
describe the composition and structure that contribute to bone strength, and also 
may be independent of bone mineral density [41, 42]. Bone might be qualitatively 
different in strength despite similar bone density. For example, in young adults, 
bone is stronger across all levels of bone density compared to bone in older 
adults. So, the concept of bone strength includes a number of characteristics of 
bone besides bone density that collectively are termed “bone quality” [43]. Thus, 
it  includes; bone turnover, microarchitecture, mineralisation, microdamage and 
composition of the bone matrix and mineral [44]. These components are 
interdependent, so often changes in one result in changes to the others. In 
particular, changes in bone turnover affect other components of bone quality 
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(such as the degree of mineralisation) and hence its measurement in clinical 
practice is of key importance [44]. 
 
1.5.1 Bone turnover 
The rate of bone remodelling is an important determinant of bone quality. It refers 
to the total volume of bone that is both resorbed and formed over a period of time 
[45]. Under ideal circumstances the amount of bone resorbed equals the amount 
reformed. Bone remodelling can be estimated in clinical practice by measuring 
circulating and excreted biochemical markers of resorption and formation [44, 
46]. In a naturally occurring OA guinea-pig model, markers of bone formation and 
resorption are reported to be higher before visible cartilage degeneration [37], 
indicating that one of the earliest changes in OA is a change in bone remodelling. 
Bone remodelling is a harmonised process of cellular activity responsible for 
bone renewal and repair. Understanding the cell biology of this process is 
essential, since abnormalities of bone remodelling may have involvement in 
metabolic bone diseases [47]. The bone remodelling cycle (Figure 1-9) begins 
with an activation phase that involves recruitment of osteoclast precursors to the 
skeletal site that is to be remodelled [47]. Next is the phase of bone resorption, 
during which osteoclasts remove bone and then undergo programmed cell death 
(apoptosis). In the final stage, bone formation takes place to replace the removed 
bone. It begins with recruitment of osteoblast precursors to the remodelling site. 
These cells then differentiate into mature osteoblasts and start to form a new 
bone matrix (osteoid), which subsequently becomes calcified to form mature 




1.5.2 Cellular components 
There are four main cell types in bone tissue; osteoprogenitor cells of the 
osteoblast lineage, osteoblasts, osteocytes, and osteoclasts (osteoclast 
progenitors are recruited to bone via the circulation), (Figures 1-9 & 1-10).  
Osteoprogenitor cells are primitive cells derived from the mesenchyme (Figure 
10a). They form in the inner layer of the periosteum and also line the marrow 
cavity, as well as Haversian and Volkmann’s canals of compact bone. During the 
period of growth and remodelling, these cells are stimulated to differentiate into 
osteoblasts that lay down new bone. They can also differentiate into other cell 
types such as fibroblasts, chondroblasts and adipose cells [51]. 
Osteoblasts are large cells with abundant basophilic cytoplasm, which originate 
from primitive mesenchymal cells. Their main function is to lay down new bone 
in the form of osteoid, which consists mainly of collagen that is essential for later 
mineralisation in the form of hydroxyapatite [52]. Deposition of mineral makes the 
bone matrix stiff, and capable of bearing loads [51].  
In the course of OA, it has been noted that osteoblasts display biological and 
morphological differences [53, 54]. Also, it has been noted that OA osteoblasts 
have altered expression of important bone factors (RANK-L: receptor activator of 
nuclear factor kappa B ligand, OPG: osteoprotegerin, IGF: insulin-like growth 
factor, PTHrP: parathyroid hormone related protein) [54]. Further, gene 
expression analysis of osteoblasts derived from hip OA showed that dysregulated 
expression of the transcription factor Twist-related protein 1 (TWIST1), 
transforming growth factor-beta (TGF1) and Mothers against decapentaplegic 
homolog 3 (SMAD3) was present in OA osteoblasts, both in vivo and ex vivo, 
suggesting that altered intrinsic properties of osteoblasts might have a role in OA 
aetiology [55, 56]. 
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resorption, reducing osteophyte size, and preventing cartilage degradation [66] 
[67]. This effect of bisphosphonates is believed to act by a direct inhibitory effect 
on osteoclasts and bone turnover [66]. However, data from human studies has 
not demonstrated a clear benefit of antiresorptive therapy in human OA [68, 69]. 
Osteocytes reside within the bone matrix, connected to each other via long cell 
extensions, which run through canaliculi (Figure 10c) [70]. Osteocytes are 
present in the bone at high density, although the number, size and position of 
osteocytes vary according to the type of bone and skeletal sites they inhabit [59, 
71]. Recently, Buenzli and Sims estimated that the total number of osteocytes 
within the average human skeleton is ~42 billion and the total number of 
osteocyte dendrites are ~3.7 trillion [72]. Furthermore, based on the average time 
of the remodelling cycle in the adult, this study estimated that 9.1 million 
osteocytes are restored on a daily basis in the skeleton, signifying the intriguing 
and dynamic nature of the osteocyte network [72]. Also, it is believed that 
osteocyte viability may play a significant role in the maintenance and integrity of 
bone quality, since it has been shown that osteocyte apoptosis has essential 
roles in the repair of microdamage in bone [73]. Osteocytes appear to have a 
number of important roles in bone [74, 75]. They possess the ability to reabsorb 
(and reform) bone mineral, in a process termed osteocytic remodelling [74]. 
Osteocytes thereby maintain the structural integrity of the mineralised matrix and 
may mediate short term release of calcium for the purpose of systemic calcium 
homeostasis in the body. Verborgt et al. described a central role for osteocytes 
in bone matrix repair [76], and more recent studies have shown that osteocytes 
direct focal modelling and remodelling by detecting strain in bone [77-80]. 
Because of this, bone with a reduced number of osteocytes, such as has been 
reported in the bone of patients with a fragility fracture, may have an impaired 
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ability to repair microdamage [81]. In OA pathogenesis, altered morphology and 
viability of osteocytes have been reported in sclerotic regions of the subchondral 
bone in OA [82]. However, osteocyte number and viability, in relation to the 
progression of OA, has not been investigated. 
In addition, it is important to mention bone tissue resident macrophages, named 
osteomacs, that are found to reside at the bone remodelling site [83]. Osteomacs 
are closely related to osteoclasts by sharing a dependence on the lineage-
specific growth factor CSF-1 [83]. However, osteomacs express the epidermal 
growth factor seven transmembrane (EGF-TM7) protein EMR1/F4/80 which 
clearly distinguishes them from osteoclasts. In vivo, osteomacs are found at the 
sites of bone modeling forming a distinctive canopy structure over mature 
osteoblasts, whereas in vitro they enhanced osteoblast mineralisation suggesting 
that osteomacs are likely to have a role in anabolic bone modelling [83, 84]. 
1.5.3 Mineralisation 
An important aspect of the material properties of bone is the degree of 
mineralisation. Overly mineralised bone tissue is more frail, and less resistant 
during impact loading, while under mineralised bone may be too flexible for the 
function it must perform [85]. Bone must at the same time be stiff enough to be 
resistant to bending and elastic during dynamic loading so it retains the same 
length without damage [86]. These contradictory properties are achieved by 
varying the mineral content of the collagen tissue of bone [85]. The mineralisation 
of the bone matrix is dependent on the age of the bone; in general older bone is 
more mineralised because of alterations in bone remodelling rates [87]. However, 
in OA, decreased mineralisation of subchondral bone has been noted in both the 
subchondral plate and trabeculae in animal models and humans [88-90].  
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1.5.4  Microarchitecture 
The high power, non-destructive imaging method of Micro Computer 
Tomography (Micro CT) has been developed to enable high resolution (5 µm-50 
µm), 3-dimensional visualisation and direct quantification of bone 
microarchitecture [44, 91, 92]. Changes in the microarchitecture of subchondral 
bone is an important characteristic of OA and it is believed to result largely from 
high joint loading. Animal OA studies have substantially contributed to the 
understanding of subchondral bone changes during progression of OA, 
suggesting that changes in subchondral microarchitecture may occur before, 
during and/or after cartilage damage [37, 38]. Furthermore, it has been 
suggested that different types of changes in subchondral bone microarchitecture 
may occur at different stages of OA disease progression. Thus, all changes and 
modifications in SCB should be treated as significant pathophysiological events 
[35]. 
In animal OA models [39, 48] the early stage of OA is characterised by a thinner 
subchondral bone plate, increased plate porosity [48, 93, 94], fewer subchondral 
bone trabeculae that are rod-like in structure and show reduced connectivity, with 
an overall decrease in bone volume [50, 95-98]. In late stage OA, changes in the 
SCB are described as a thicker subchondral bone plate, increased trabecular 
bone density, trabecular thickness and trabecular number, while the separation 
between trabeculae is decreased and transformation of trabeculae from rod-like 
into plate-like is evident [99-101]. However, these findings have not been 
observed consistently [33, 102].  
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Recently, it has been suggested that according to the features of subchondral 
bone (sclerotic and non-sclerotic trabecular bone), two subtypes of OA exist, 
suggesting different mechanisms of disease progression [103]. Also, it has been 
noted that specific changes, such as an increase in trabecular thickness, closely 
correlate with increased cartilage histological grade (increased degradation) 
[104], while an increase in trabecular number and a decrease in separation and 
SMI associates with loss of cartilage volume [40, 105]. Furthermore, it was 
deduced from a guinea pig OA study that retention of a rod-like structure might 
protect cartilage from damage during impact loading [105]. It is also important to 
apply an optimal measure parameter for assessment of plate/rod geometry in 




Microscopic bone damage (microdamage) is an important aspect of bone quality, 
with biomechanical relevance. Microdamage may occur in one or more of the 
constituents of bone’s material composition, and at nano-, micro-or macro 
structural levels (Figure 1-11) [86]. The accumulation of microdamage in bone 
tissue contributes to reduced bone strength, stiffness and resistance to 
mechanical loading [51], factors that may subsequently contribute to the 
progression of OA [107]. Microdamage in bone tissue may be present in the form 
of microfractures, linear microcracks [107] and diffuse damage [108] that each 







intraosseous pressure and capillary permeability, associated with loss of cartilage 
volume and increased bone remodelling [122, 126]. Although it seems that 
vascular pathology may be important in OA, only a few human studies have 
investigated a direct role for the vasculature in the pathogenesis of OA. There 
have been no studies that have investigated the quantity and quality of blood 
vessels in OA subchondral bone. Thus, the relationship between blood vessels 
and changes in the subchondral bone due to OA are not fully understood. 
Understanding the role of vascularisation in subchondral bone could provide 
benefits for the development of appropriate therapies [2]. 
 
1.6 Subchondral bone imaging features in KOA 
1.6.1 Osteophytes 
Osteophyte formation is one of the most commonly seen radiographic features 
in OA. In the knee, osteophytes are usually found at the margins of the joint and 
their presence is an important criterion for the diagnosis of KOA (Figure 1-15). It 
has been found that the presence of osteophytes has significant clinical impact 
in KOA, where they  associate with pain, loss of joint function and decreased 
mobility. However, it is important to state that two large longitudinal studies 
reported that there is no significant positive association between osteophytes and 
pain [127, 128]. Growth factors such as TGF-beta appear to play a major role in 
both chondrogenesis and osteophyte formation [129, 130]. Osteophytes can be 
seen early in the development of OA and prior to joint space narrowing [131]. It 
has also been suggested that the presence of osteophytes in the knee might 
have a protective role, as they often develop in the posterior and anterior aspect 




acceptable theory is one of bone contusion, a possible consequence of traumatic 
bone necrosis after the impact of two opposing articular surfaces [137].  
Studies that examined the relationship between subchondral bone cysts and 
clinical symptoms such as knee pain found conflicting evidence [128, 138]. 
However, the relationship between subchondral bone cysts and 
structuralchanges in the knee has been demonstrated in several studies [9]. In 
individuals with OA, over a 24-month period, the development of new cysts and 
the progression of existing cysts were positively associated with cartilage volume 
loss [139]. Also, a positive correlation was found between mean cyst size change 
(mm) and cartilage loss in the medial femoral condyle [139]. In a separate study, 
subjects with cysts had lower mean tibial cartilage volume at baseline, and 
greater loss of medial tibial cartilage volume over a 2-year period, as well as an 
increased risk of knee-joint replacement over a 4-year period. These findings 
suggest that the presence of a subchondral bone cyst is in association with 
severe structural changes and poor clinical outcomes [9]. 
1.6.3 Bone marrow lesions 
One of the most interesting subchondral bone pathologies in KOA imaged by MRI 
is the bone marrow lesion (BML), (Figure 1-17). Its significance in KOA 
pathophysiology is reflected by a close relationship with both clinical symptoms 
and structural degradation. From a large number of clinical studies, it has been 
suggested that BMLs may be valuable imaging biomarkers, offering information 
regarding initiation, progression and potential outcome in KOA. Furthermore, 
BMLs are identified in subchondral bone in both symptomatic and asymptomatic 
patients and it has been shown that BMLs are dynamic, with the ability to appear 
and disappear over time [140-143]. This suggests that BMLs might be modifiable 
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features and as such might be potential targets or outcome measures for OA 
treatments.  
 
Figure 1-17: MRI of the tibial plateau (sagittal view) of a 62-year-old female 
KOA patient taken ex-vivo (post knee replacement surgery). In PDFS-
weighted sequences, BMLs (purple oval shape) are visualised as an ill-
defined area of hyper-intense signal. In T1-weighted sequences, BMLs 
appear as a hypo-intense signal.  
1.7 BML in the progression of KOA 
A BML is defined as an ill-defined area of hyper-intense signal on fluid sensitive 
sequences (T2-weighted, PD-proton density weighted, PDFS-proton density fat 
suppressed, FSE-fast spin echo and STIR-short tau inversion recovery) or as a 
hypo-intense signal on fat sensitive sequences (T1-weighted), compared to 
normal subchondral bone appearance (Figure 1-17), [142, 144]. A BML is a 
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specific signal detected only by MRI and cannot be visualised by x-ray, ultrasound 
or CT [142, 145]. 
Wilson et al. were the first to describe this subchondral bone pathology and 
referred to it as “Oedema-like Lesions” or “Bone Marrow Oedema” [146]. Later, 
this term was replaced, based on histology findings, with the more appropriate 
and currently used term by the OA research community “Bone Marrow Lesion” or 
“BML” [25]. A similar MRI signal in bone is observed in several other pathologies, 
such as rheumatoid arthritis, trauma, stress fracture, and vertebral Modic 
changes in the spine [142]. However, when a BML is present in conjunction with 
clinical symptoms, it is indicative of specific OA pathology. This review will 
specifically describe BMLs related to OA. While the majority of the OA research 
has described BMLs in the knee joint, it is important to state that BMLs are seen 
in other joints, including the hip [147-149], hand [150] shoulder [151], foot and 
ankle [152, 153]. BMLs have also been observed in animal OA models [154, 155]. 
The choice of the appropriate MR sequence in the assessment of BMLs is of 
critical importance. Fluid sensitive sequences such as T2-weighted, PD-weighted 
or PDFS-weighted are among those that are the most appropriate and 
recommended for use to delineate the maximum extent of a BML [24, 156]. 
Several studies have indicated that sequences such as gradient-echo sequences 
(eg. dual-echo steady state [DESS], fast low-angle shot [FLASH], or spoiled-
gradient-recalled [SPGR] acquisition in steady state) are less sensitive for BML 
detection and therefore not appropriate for BML assessment [8, 10, 157-160]. 
1.7.1 Characteristics of OA BMLs  
The prevalence of BMLs is much higher in established OA (painful with 
radiographic evidence of loss of joint space), where it has been reported to vary 
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between 50-80% [11, 12, 161], compared to asymptomatic joints, where it is 
around 15% [141]. There are conflicting data regarding the presence of BMLs 
and gender. Davies-Tuck et al. found that there is no association between the 
presence, development or persistence of BML and gender [141]. However, it was 
also reported that males were more likely to have BMLs than females, and that 
BMLs in males are larger and more likely to increase in size over time [12, 162]. 
The size of BMLs is measured quantitatively as BML volume (expressed in mm3) 
or as the largest diameter (expressed in mm) of the lesion on MRI [128, 163], and 
semi-quantitatively by using whole organ scoring systems; WORMS, KOSS, 
BLOKS and MOAKS [25]. While it is more practical to use whole organ scoring 
systems, as they have a 4-point grading score (0 as no lesion, 1=BML occupy up 
to 25% of the region, 2=25%-50% of region and 3=BML occupy more than 50% 
of the region), quantitative methods are more sensitive and more reliable for 
following up changes longitudinally [22]. The average diameter of BMLs in KOA 
is reported to be from <0.5 to >2 cm [128, 163]. 
Importantly, BMLs have the ability to change in size. Over time, BMLs may 
enlarge, regress or completely disappear [140, 143, 163] [164]. However, the 
existence of BMLs is quite variable. In healthy and asymptomatic populations, 
two studies reported that a high proportion of BMLs (46%) completely resolved 
over 2 years [140, 141]. However, in KOA populations observations are much 
more diverse. Hunter et al. assessed 217 KOA patients and performed MRI at 
baseline, 15 months and 30 months follow-up and found that over time BMLs 
often become larger and that less than 1% of the cohort showed a reduction in 
size or resolution [164]. Roemer et al. assessed 395 KOA patients over 30 
months and found that more than 60% of BMLs changed in size, with almost 50% 
showing reduction in size or complete resolution [140, 143]. Similarly, Phan et al. 
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reported both a decrease and an increase in BML score over 2 years [163]. 
Furthermore, Garnero et al. and Felson et al. reported that BML size can fluctuate 
in a matter of weeks [165, 166]. Finally, Foong et al. observed 198 subjects over 
eight years and found that the proportion of BMLs increasing and decreasing in 
size is very similar (24% and 21%, respectively) while the majority (55%) 
remained stable [162]. 
 
1.7.2 Histopathology of BML 
Zanetti et al. were one of the first to investigate and describe the histology of 
BMLs [167]. Surprisingly, they found that oedema is minimally present and 
suggested that an adequate term for these features would be “Bone Marrow 
Lesion” [167]. Since then only a few histological studies have been performed 
that explore BML at the tissue level. Those studies mainly indicated the presence 
of non-specific pathologies and a mixture of abnormalities such as necrosis, 
fibrosis, oedema, fibro-vascular ingrowth in the bone marrow, and abnormal 
trabeculae with evidence of microfractures [147, 148, 154, 167-169]. Similarly, 
BML histopathology findings have been reported in animal models of OA [154]. 
Results from those studies were unable to find a specific histopathology of BML 
or to explain the MR signal [148, 155, 170]. Also, none of the histological studies 
explored whether BMLs seen using water sensitive and/or fat sensitive MR 
sequences are different at the tissue level. 
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1.7.3 BML and clinical symptoms 
BMLs are closely associated with OA related symptoms such as pain. Felson et 
al. was the first to report an association between painful knees and BMLs [11]. 
Since then, several other studies have confirmed this association [138, 171-174]. 
It has been hypothesized that fibro-vascular replacement of fatty bone marrow 
within BML areas might be a potential source of the pain in OA [175]. However, 
the exact source of the pain is still unknown. Larger BMLs and/or increased BML 
size are associated with increased knee pain in OA patients [176-178]. Also, a 
decrease in size and/or resolution of BML resulted in less pain and reduced 
cartilage loss [176, 178].  
 
1.7.4 BML and structural degradation  
Both cross sectional and longitudinal studies indicate that there is an association 
between the presence of a BML, BML progression and formation of new BMLs, 
and cartilage damage in the same location [141, 143, 164, 179, 180]. The 
presence of a BML at baseline has been related to compartment specific 
deterioration [11, 181], and the size of a BML is considered to be the main 
determinant factor in association with increased cartilage loss and subchondral 
attrition [178, 182]. In three knee studies, micro-computed tomography was used, 
showing that the structure of the subchondral bone within the zone of a BML was 
much more variable compared to the subchondral bone without a BML [168, 183, 
184]. Specifically, subchondral bone in BML zones was characterised by a focal 
sclerotic appearance; thick subchondral plate, increased bone volume 
percentage, more trabeculae, which were thicker and less separated and more 
plate-like [168, 183, 184]. Also, the presence of a medial BML associates with 
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subsequently increased local bone mineral density (BMD) in the medial 
compartment [185]. Several more studies have confirmed that the presence of 
BMLs is strongly associated with increased local BMD but not with distant BMD 
[186, 187], higher relative medial tibial bone density, less mineralisation and 
variable bone microarchitecture [168, 183]. Lowitz et al. found increased BMD, 
measured precisely in areas of BML, compared to surrounding areas [188]. In 
addition, an association between BMLs and subchondral cyst formation has been 
found [137]. In longitudinal studies, the subchondral bone within BMLs was 
associated with the appearance of cysts over time, suggesting that BMLs might 
be an early cystic formation [136, 137, 189]. However, the relationship between 
BMLs and subchondral cysts remains unclear, as not all BMLs will give rise to 
cysts [136]. 
1.7.5 BML development in the tissue 
Despite the fact that BMLs are often observed in clinical studies of KOA, their 
pathogenesis is poorly understood. There is evidence that the presence of BMLs 
in knee joints is related to greater mechanical loading [190]. It has been reported 
that high loads increase the risk of the presence and progression of BML [144]. 
Also, BMLs are related to dynamic knee loading and knee adduction moments 
[190, 191]. Knee malalignment is associated with both the incidence and 
progression of BML [156]. These findings strongly support the hypothesis that 
greater mechanical loading of the medial compartment plays a role in the 
pathogenesis of BML in KOA [190]. 
Another theory regarding the formation of BMLs is based on the water-like signal 
on MR sequences. However, the histology of BMLs indicates minimal oedema 
[167]. Thus, it was proposed that BMLs might represent an area of capillary 
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leakage caused by a local change in capillary walls or by increased vascular 
pressure due to increased blood flow to bone marrow or decreased venous 
clearance in the marrow space [124, 192]. This possibility was later partially 
supported by histological findings of increased fibrovascular ingrowth and 
vascular fibrosis in areas of BML [148, 169], although BMLs persist in bone ex 
vivo [154, 183]. 
Finally, there is a theory that the presence of a BML might be in association with 
systemic metabolic factors. A few studies indicated that dietary factors such as 
saturated fatty acid intake, increased serum cholesterol and triglycerides 
associated with the incidence of BMLs [193-195]. 
The cause of the formation of BMLs in subchondral tissue is most likely 
multifactorial. However, more tissue-based evidence is required to understand 
what factors contribute to the initiation of BMLs and what factors contribute to 
their healing or enlargement. Given the important role of BML in OA, identifying 
these contributing factors may ultimately identify targets for the treatment and 
prevention of knee OA. 
 
1.7.6 Possible treatments for BMLs 
Currently, there are no approved drugs to modify the structural progression of 
OA. For patients with severe pain associated with degenerative OA changes, 
TKR is often recommended. However, TKR is an invasive surgery that is 
associated with significant cost, postoperative complications, morbidity and 
occasional mortality. Being that BMLs closely correlate with symptoms and 
structural degeneration, and have the ability to regress and can be monitored 
closely by MRI, they represent potential therapeutic targets. 
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The novel technique named “subchondroplasty” has been proposed as a method 
to treat areas of BML, on the basis that they are areas of non-healing bone [196-
198]. The technique involves injecting a calcium phosphate paste (synthetic bone 
void filler) into the BML zone to promote bone healing. Only two (non-randomized 
controlled trial) studies have evaluated the efficacy of this method for a small 
number of patients. The first study of 59 patients, 25% of whom had continued 
pain and elected to undergo TKR, reported the remainder of the patients having 
pain improvement in the first 6 months [198]. The second study of only 5 patients 
reported an improvement in pain and functional capacity in patient follow up at 6, 
12 and 24 months after surgery [197]. 
Other studies have proposed the use of anti-resorptive therapies, based on 
animal studies, in which this approach has shown efficacy to prevent or slow the 
progression of OA. Laslett et al., in a pilot study, reported a reduction in the size 
of BMLs and a reduction in pain after 6 months of treatment with zoledronic acid 
[199]. Strontium ranelate reduced cartilage volume loss and decreased the total 
BML score over 36 months [200]. In both studies, better results were recorded in 
individuals with less structural degeneration, suggesting that early treatment 
might be more effective. The full benefit of these proposed therapies and 
treatments is poorly known. Given that BMLs detected in established OA (with 
pain and radiographic progression) appear to resolve less often compared to 
those in asymptomatic populations, individualised and early treatment may be a 
more appropriate solution for individuals diagnosed with BMLs. Also, there is the 
possibility that the difference in the appearance of BMLs on different MRI 
sequences may indicate different tissue processes, which might be an important 
indicator for the choice of treatment. Thus, there is an urgent need to investigate 
if and how BML monitoring can be useful as a clinical tool. 
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1.8 Summary and research gap 
Improvement in imaging modalities has opened a new door for understanding the 
aetiology of OA. Hence, there is no doubt that changes in the subchondral bone 
are important in the initiation, development and progression of KOA. However, 
the pathogenesis of human OA disease is still vague. Obtaining early OA tissue 
samples is difficult, and because OA is a slowly progressing disease it would take 
a long time to follow disease progression from early stage to advanced stage. 
There is a need for a disease-specific biomarker. The OA research community 
consensus is that BMLs in the subchondral bone are of considerable interest as 
they have strong association with both clinical symptoms and structural changes 
in the OCU. Moreover, these features show the ability to reduce in size and even 
to completely resolve in affected tissue, resulting in pain reduction. Hence, it has 
been suggested that BMLs could act as potential targets or bio-indicators in the 
prevention and treatment of OA. 
However, BMLs are complex formations and what they represent at the tissue 
level, or what mechanisms lead to BML development in bone tissue is not well 
understood. Understanding of the structural and cellular nature of BMLs is 
necessary for their rational use as imaging biomarkers in the future management 




1.9 Research objectives  
The research described in this thesis sought to learn more about the relationships 
that exist between the presence of BMLs and the progression of human KOA. 
Specifically, four individual studies were carried out to comprehensively 
investigate BMLs at the tissue level and their relationship with the structural 
progression of OA.  
Hypothesis: BML imaged using MRI reflect changes in subchondral tissue of 
proximal tibia that related to OA disease severity and/or progression.  
Thesis Aims: 
 To investigate the histopathology of the human OCU (cartilage, subchondral 
bone and subchondral bone marrow) based on the presence or absence of 
a BML. 
 To perform comprehensive tissue characterization of BMLs detected using 
two specific MRI sequences in human KOA. 
 To explore the mechanisms, by which BMLs might develop in the tissue and 
which might influence the progression of human KOA.  
 To evaluate subchondral bone microarchitectural changes across the whole 
human tibial plateau in order to understand what role the presence/absence 
of a BML might play locally and to surrounding regions.  
Chapter 2 is a recently published study, which characterised human KOA BMLs 
imaged using two different MRI sequences at the tissue level. Chapter 3 
describes a study, in which causal factors of BML formation were investigated. 
Evidence of high mechanical loading and vascular pathology were investigated 
by assessing the accumulation of microdamage, and the qualitative and 
quantitative aspects of blood vessels in BML and non-BML tissue. Chapter 4 
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describes a study of investigating a potential role for components of the metabolic 
syndrome in BML development in KOA. Chapter 5 describes a study investigating 
a microarchitectural changes in whole tibial plateaus, based on the 
presence/absence of a BML. Tissue from healthy/control knees was compared 
with that from OA with no BML and OA with BML, to better understand the course 
of OA disease and BML involvement in disease progression 
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Introduction: Epidemiological studies demonstrate a link between knee 
osteoarthritis (KOA) and the metabolic syndrome (MetS) and its components. 
The presence of a bone marrow lesion (BML) in KOA is a strong predictor of 
structural degeneration and severity of the symptoms. However, little is known 
regarding the influence of metabolic factors on BML development in the 
subchondral bone of the knee. Therefore, this study aimed to investigate 
association between MetS, its components and BML in KOA subjects. 
Methods: Tibial plateaus and medical histories were obtained from 73 patients 
(41 females, 32 males) aged 48-87 years, undergoing knee arthroplasty for KOA. 
To identify BMLs in tibial plateaus, MRI scans were performed ex vivo, using T1 
and PDFS-weighted sequences. For each patient, relevant clinical data of age 
and body mass index (BMI) were recorded on day of surgery. Data on 
comorbidities and medication (including antidiabetic treatment, antihypertensive 
medication and dyslipidaemia treatment) were retrieved from clinical histories 
and medical records. 
Results: An increased prevalence of MetS was found in KOA subjects with BMLs 
compared to those without BML (p=0.02). Furthermore, high total cholesterol and 
high body mass index showed significant association with radiographic OA 
severity (high KL grade and loss of cartilage volume), while high fasting glucose 
and high triglycerides were significantly associated with larger BML size (higher 
BML volume). 
Discussion: Our data suggest that a combination of specific metabolic factors 
might promote the occurrence of BMLs in subchondral bone tissue and that 
metabolic factors might contribute to the progressive osteochondral degeneration 
of KOA.   
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4.1 Introduction 
Systemic and metabolic factors, such as nutritional intake [1, 2] and serum lipids 
[3], have been linked with knee osteoarthritis (KOA). In addition, the presence of 
metabolic syndrome (MetS) and its components might be a causative factor for 
the initiation and progression of KOA and may influence the enlargement of bone 
marrow lesions (BMLs) [4-6].  
Visualised by magnetic resonance imaging (MRI), BMLs act as a valuable 
imaging indicator of the structural degenerative progression in KOA [7-9], and as 
a predictor of future potential intervention outcome such as total knee 
replacement [10]. At the tissue level, they have been described as areas of 
subchondral bone with impaired bone quality [7, 8, 11] and nonspecific changes 
in bone marrow such as fibrotic and necrotic changes, with fatty marrow and 
numerous vascular infiltrations [7, 11, 12]. An interesting finding for BMLs is that 
in pre-OA populations BMLs can resolve within two years in up to 50% of 
individuals [13], while in established OA they are less likely to decrease in size or 
resolve [14]. Thus, in early OA, MRI identified BMLs might provide potential 
targets for therapeutic intervention. Further, our recent data indicated that 
presence of BML subtypes, detected by different MRI sequences, in tibial 
subchondral bone, identify more or less severe KOA [7]. This further opens the 
possibility of identifying individuals with less severe KOA, perhaps at an earlier 
stage of progression, which may be amenable to therapeutic intervention.  
It is not known whether metabolic factors have direct or indirect relationship to 
the formation and presence of BMLs. We hypothesised that individuals with tibial 
BML suffer from metabolic conditions and have increased incidence of MetS. 
Therefore, the aim of this study was to explore the relationship between the 
metabolic syndrome and its components and the presence of BMLs in subjects 
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with KOA. This potentially could uncover modifiable risk factors for BML in KOA, 
information that could perhaps be used to influence the understanding of KOA 
pathogenesis and lead to novel and more personalised/individualised treatments 
for this condition, at least in early disease  
 
4.2 Methodology 
4.2.1 Clinical characteristics of the patient cohort 
Tibial plateau and medical histories from 73 patients undergoing knee 
arthroplasty surgery, of whom 41 (56%) were females, aged 48 to 86 years, and 
32 (44%) were males, aged 49 to 87 years, were included in the study. Tibial 
plateaus were scanned ex vivo using MRI to detect presence of BMLs as 
previously described [7]. For each patient, relevant clinical data of age, and body 
mass index (BMI) were recorded. BMI categories were defined according to the 
recommendation of the Australian Department of Health: normal BMI range 19-
25, overweight BMI 25-30, obese BMI 30-35 and severely obese >35. Patients 
were fasted overnight, and pre-surgery blood samples were taken for the 
measurement of glucose, total cholesterol and triglyceride levels. Blood pressure 
was measured twice, and the average of two measurements was calculated. 
Data on comorbidities and medication (including antidiabetic treatment, 
antihypertensive medication and dyslipidaemia treatment) were retrieved from 
clinical histories and medical records. According to the World Health Organisation 
(WHO), metabolic syndrome (MetS) was defined as the presence of three or 
more of the following components: 1) central obesity with BMI 30 or greater, 2) 
dyslipidaemia or use of medication for dyslipidaemia, 3) blood pressure of 130/85 
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or greater or use of antihypertensive medication, and 4) fasting glucose level 
greater than 5.5 mmol/L or medication for diabetes mellitus [15, 16]. 
Informed written consent was obtained from all patients and the study received 
prior approval from the Human Research Ethics Committee at the Repatriation 
General Hospital, the Royal Adelaide Hospital and The University of Adelaide, 
South Australia, in accordance with the Declaration of Helsinki 1975. Inclusion 
criteria were: radiographic OA with severe symptomatic disabilities, such as 
severe pain and limited mobility. Exclusion criteria were: secondary OA of the 
knee due to trauma, rheumatoid arthritis, osteoporosis, evidence of bone-related 
chronic debilitating disease and/or history of any medication that may have 
affected bone turnover. 
 
4.2.2 Radiographic evaluation of knee OA 
Standing anteroposterior, posteroanterior and lateral view radiographs were 
taken of OA subjects prior to surgery. The extent of radiographic progression was 
assessed according to Kellgren and Lawrence (K&L) grade. All radiographs were 
scored by two experienced assessors (AW and YW), with 95% agreement. 
Assessors were blinded for the presence of BMLs in the knee joint.  
 
4.2.3 Magnetic resonance imaging (MRI) 
Each TP was MR imaged ex vivo in an 8-channel wrist coil (3T MRI Siemens 
TRIO, Royal Adelaide Hospital, Adelaide), using two specific sequences; fat 
suppressed fast spin-echo proton density-weighted (PDFS) and T1-weighted 
spin echo in the sagittal and coronal plane. Sagittal slice thickness was 1.6 mm, 
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with distance factor of 25%. Coronal slice thickness was 1.6 mm, with 10% 
distance factor. A BML was defined as a zone of altered signal intensity in the 
bone and marrow located immediately beneath the articular cartilage and visible 
on at least two consecutive slices [17, 18]. Cartilage volume and BML volume 
were assessed by two researchers (DM and YL), as described previously [18]. 
The coefficient of variation for the measurement of cartilage volume in the medial 
and lateral compartment was 2.2% and for BML volume 2.4%. 
 
4.2.4 Statistical analysis 
Student's t test and chi square tests were used to compare the distribution of 
characteristics between groups. The difference between No BML vs BML (BML 
1+BML 2) groups was analysed, followed by analysis of the difference between 
BML 1 vs BML 2. The critical value for statistical significance was chosen as 
P<0.05. The analyses were performed using the GraphPad Prism software 
(GraphPad Software, Inc., USA). 
Both adjusting for clustering on subject and controlling for the confounders age, 
sex and BMI and presence of BML, were performed in linear mixed-effects 
models. Linear mixed-effects models were also used to investigate the 
association between cartilage volume vs each MetS component separately and 
as the number of MetS components, K&L grade vs each MetS component 
separately and as the number of metabolic components present, and BML 
volume vs each MetS component separately and as the number of MetS 
components present. Adjustment for multiple comparisons was made using a 
Sidak adjustment to account for significance of P values by chance due to large 
numbers of regressions being performed. These analyses were performed using 
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the statistical software SAS 9.4 (SAS Institute Inc., Cary, NC, USA). 
 
4.3 Results 
Fifty-five (76%) of the TP samples contained a BML detected with one or both 
MRI sequences. BMLs detected using the PDFS sequence only (BML 1) 
represented 62% of all BMLs. BMLs detected by both PDFS and T1 sequences 
(BML 2) represented 38% of all BMLs.  
4.3.1 Demographic characteristics  
4.3.1.1 Age and gender 
Eighteen patients did not show a BML on MRI (No BML group). This group was 
composed predominantly of females (13; 72%). The average age for the No BML 
group was 71.5 years. The female age range was 64 to 84 years, and the male 
age range was 60 to 80 years. 95% of individuals from the No BML group were 
65 to 75 years of age.  
The BML group contained almost equal proportions of females and males (51%, 
49%, respectively). The average age of the BML group was 68.7 years. The 
female ages ranged from 49 to 87 years, and the male age range was from 48 to 
86 years. In the BML group, 31% of individuals were younger than 65 years and 
65% were between 65 and 85 years of age. These data are summarised in Table 
1. 
 
4.3.1.2 Body mass index (BMI) 
In the No BML group, 11 (61%) were obese or severely obese, with an average 
BMI of 34. 70% of females were obese or severely obese. The BML group had 
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an average BMI of 30 and approximately 50% were in the obese or severely 
obese category, while 16% had ideal weight. About 60% of females were obese 
or severely obese compared to 33% of males. Observing BML 1 and BML 2 
separately, we found that both groups had an average BMI of 31. These data are 
summarised in Table 2. 
 
4.3.1.3 Metabolic Syndrome (MetS) 
For each individual, components of the MetS were documented separately and 
as the co-occurrence of at least 3 components (defined as MetS). Individuals in 
the No BML group had an average fasting glucose level of 5.9 mmol/L, blood 
pressure of 140/80, serum total cholesterol level of 4.5 mmol/L and triglycerides 
of 1.6 mmol/L. Observing females and males separately, elevated levels for some 
MetS components were detected in the No BML group, with 2/3 of the females 
having elevated fasting blood glucose and 2/3 of the males having elevated 
systolic blood pressure. In the BML group, the average fasting glucose level was 
6.2 mmol/L, blood pressure of 140/80, serum total cholesterol level of 4.9 mmol/L 
and total triglycerides of 1.4 mmol/L. More than 50% of the individuals in the BML 
group had above normal fasting glucose levels (>5.5 mmol/L), elevated systolic 
blood pressure or use of antihypertensive medication. These data are 
summarised in Table 3. 
 
4.3.2 Differences between groups 
There were no significant differences in the patient’s age, gender or K&L grade 
between the BML and no BML group. Individuals in the no BML group had a 
higher mean BMI than the BML group (p=0.04). However, when we investigated 
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differences according to BMI category, healthy, overweight, obese and severely 
obese, no significant difference was found between groups. The volume of 
cartilage was significantly higher in the No BML than the BML group (p=0.01). 
Comparing prevalence of metabolic components separately between BML and 
no BML, a high prevalence of established hypertension (use of antihypertensive 
medication) was found only in the BML group (74%, 41 out of 55), (p=0.005). 
MetS prevalence (co-occurrence of at least 3 components) was significantly 
greater in the BML group compared to the no BML (p= 0.02). This remained 
significant after adjusting for age, sex and BMI.  
In the BML group, a significant difference was found between the BML1 and 
BML2 subgroups, such that radiographic progression (K&L grade) was lower and 
cartilage volume was higher in BML 1 compared to BML 2 (p=0.04, 0.006, 
respectively). In regard to metabolic components, the total cholesterol and the 
number of patients with elevated total cholesterol were significantly higher in BML 
1 compared to BML 2 (p=0.008 and p= 0.02, respectively). These data are 
summarised in Table 3. 
 
4.3.3 Correlations between each metabolic component separately and as 
the number of metabolic components present vs. cartilage volume, 
K&L grade and BML volume 
BMI was positively correlated with K&L grade in No BML (r=0.49, p=0.04) and 
BML 1 (r=0.47, p=0.03). Total cholesterol levels also correlated positively with 
K&L grade (r=0.66, p=0.001) in the BML group (BML 1+BML 2) and in the BML 
1 group (r=0.65, p=0.001), and with cartilage volume in the BML group (r=0.50, 
p=0.004). There was a positive association between triglyceride level and BML 
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volume in the BML group (r=0.33, p=0.04) and in the BML 1 group (r=0.58, 
p=0.01). Levels of fasting glucose associated positively with BML volume in the 
BML 1 group (r=0.33, p= 0.04), and negatively with cartilage volume in the No 
BML group (r=-0.57, p=0.04). No significant correlation was found between the 
severity of MetS (represented by the number of MetS components present) with 
K&L grade, cartilage volume, or BML volume, for any group. 
 
4.4 Discussion 
This study is the first to explore the association between the presence of MetS, 
as a cluster of three or more metabolic disorders [15], and its components, with 
the presence or absence of BMLs in KOA subjects. We found an increased 
prevalence of MetS in KOA subjects with BMLs compared to those without a 
BML. Furthermore, high total cholesterol and high BMI showed significant 
association with OA severity (high K&L grade and loss of cartilage volume), while 
high fasting glucose and high triglycerides were significantly associated with 
larger BML (higher BML volume). These relationships persisted after adjustment 
for age, sex and BMI. Collectively, these results suggest the possible involvement 
of metabolic factors in the development of BMLs and the progression of KOA. 
Obesity is a major risk factor for the initiation and progression of KOA [19]. 
However, only a weak association was reported previously between obesity and 
the presence of BMLs in young individuals [20], and a moderate association was 
found in an older population [21]. Weight loss did not have a positive impact on 
tibiofemoral BML size scores, suggesting that BMLs do not respond to a rapidly 
decreased body weight [22]. The results from the present study indicate that 
obesity (defined as BMI ≥ 30 kg/m2) was present in both subjects with BML and 
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in those without BML. Moreover, high BMI associates with higher K&L grade in 
both no BML and BML, suggesting that BMI might be a contributing factor of 
radiographic progression in KOA but not the key factor for BML development in 
the tissue. However, in the knee joint, in addition to excessive and/or misdirected 
biomechanical load, the way that the joint is loaded, together with the amount and 
frequency of loading is important to take in consideration. These data were not 
available for the current study and further study will be required to interrogate this 
issue.  
There is published evidence that obesity and bone metabolism are closely 
interconnected. Fat cells, the adipocytes, and the bone forming cells, the 
osteoblasts, share the same origin from multipotent mesenchymal stem cells [23]. 
Therefore, increased adipocyte differentiation might indirectly decrease 
osteoblast differentiation and bone formation/mineralisation [24]. Furthermore, it 
has been reported that high fat intake may affect calcium absorption and 
decrease bone formation/mineralisation [25]. Animal studies have demonstrated 
that lipid and lipoprotein oxidation by-products inhibit differentiation and function 
of osteoblasts [26, 27] and that hypercholesterolemia promotes osteoclastic 
differentiation and bone resorption. More recent human studies reported that 
dietary lipids, such as mono-saturated fatty acids, increase the risk of BML in a 
healthy population [28] and that increased levels of total serum cholesterol and 
triglycerides were associated with the development of new BMLs in knees over 2 
years [29]. Collectively, these data suggest a tight association between dietary 
fat and bone turnover in health and disease.  
Another important aspect of obesity is that fat tissue can produce pro-
inflammatory cytokines/adipokines [19, 30, 31]. Synovial fluid and plasma in OA 
patients contain an increased level of leptin (pro-inflammatory) and decreased 
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level of adiponectin (anti-inflammatory), [32, 33]. Elevated leptin in serum and/or 
synovia associates with MRI-defined cartilage defects, the presence of BMLs and 
osteophytes, meniscal abnormalities, and synovitis and therefore thought to play 
significant roles in bone metabolism and the maintenance of an inflammatory 
state in the joint [34-37]. On the other hand, leptin is closely associated with the 
prevalence of cardiovascular diseases, including hypertension, atherosclerosis, 
and MetS [38, 39]. Interestingly, animal studies indicate leptin as one of the key 
regulators of TGF- [32]. TGF- has a beneficial role in cartilage repair in OA 
[40], but prolonged exposure has adverse effects on bone remodelling and can 
trigger degenerative changes in both cartilage and subchondral bone [41]. Also, 
elevated serum concentrations of TGF- associate with incidence of type 2 
diabetes and play a role in the pathogenesis of hypertension [39]. Recently, in 
the same patient cohort as reported here, we found thickening of the arteriolar 
smooth muscle layer and increased lumen ratio in areas of BML (Chapter 3), 
consistent with arteriolosclerosis. The observed change in wall structure is 
possibly a compensatory response to sustained hypertension, consistent with our 
finding that hypertension was significantly more prevalent in subjects with tibial 
BMLs than in those without BMLs. Structural changes of the arteriolar wall due to 
hypertension and increased lipid levels can lead to vasoconstriction and 
ischaemic events in tissues, a possible mechanism of BML development [42]. 
Moreover, the presence of hypertension and type 2 diabetes mellitus has been 
linked to aberrant endothelial cell behaviour [43], which in turn could affect 
osteoblastic function [44-46]. Complementary to this, we reported that BML 
subchondral bone (subchondral plate and subchondral trabeculae) is 
characterised by increased osteoid thickness and osteoid volume as well as with 
higher bone volume [7]. Moreover, Hunter et. al reported that BML subchondral 
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bone is sclerotic and hypo-mineralised [8]. Collectively, pathological changes of 
the microvasculature might be caused by MetS and together contribute to the 
pathogenesis of BML. 
High levels of glucose and/or the presence of diabetes mellitus associates 
positively with structural degradation in the joint, such as cartilage volume loss 
and incidence of new BMLs in a non-OA population [47], while in an OA 
population diabetes associates with OA progression and increased incidence of 
total joint replacement [48-50]. Our finding of a positive association between 
increased levels of glucose and higher volume size of BMLs complements those 
studies. Moreover, many studies indicated that hyperglycaemia could influence 
bone metabolism at the cellular level by direct reduction in osteoblast maturation, 
function and viability, causing bone hypomineralisation [51, 52]. A high level of 
glucose stimulates differentiation of bone marrow mesenchymal cells into 
adipocytes, which results in an increased rate of adipogenesis and decreased 
osteogenesis [53]. Insulin and insulin analogue IGF-1 can directly or indirectly 
induce osteoblast proliferation, increase bone deposition and decrease bone 
resorption [54-56]. Furthermore, an association between diabetes mellitus and 
abnormalities in bone metabolism, including increased porosity of the 
subchondral plate and changes in subchondral trabeculae, reduced serum 
biomarkers of bone turnover, accumulation of non-healing microfractures and 
elevated sclerostin levels has been noted [57]. Collectively, those changes are 
indicative of reduced bone quality in patients with diabetes mellitus [58]. 
Furthermore, several studies reported that bone healing is prolonged in diabetic 
patients [57]. The presence of a BML in KOA was considered to be a sign of an 
active response to acute tissue injury [59]. Therefore, it is possible that the 
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presence of MetS in KOA subjects with BML impairs the process of healing and 
thus accelerates degenerative changes in both bone and cartilage.  
Regarding the association between MetS as a cluster of three or more metabolic 
disorders and the presence of BML in KOA, our results indicate a higher 
prevalence of MetS in OA subjects with BMLs. However, there was no 
association between the number of MetS components, higher K&L grade, lower 
cartilage volume and BML volume. This might be explained by previous reports, 
in which an association between the number of components and radiographic 
progression was found prior to adjustment for BMI, yet after adjustment 
association was weak [30]. We also found that the majority of significant 
associations between elevated metabolic components (higher BMI, higher 
cholesterol, high triglycerides and higher fasting glucose) and higher K&L grade 
and BML volume were for BML 1. We previously described BML 1 as lesions with 
less structural degeneration, compared to BML 2, and we proposed that those 
lesions might characterise OA that has a greater ability to respond to treatment. 
In addition, results from this study suggest that the negative effect of specific 
metabolic components might be important in an early stage of OA progression. 
Hence, targeting those metabolic components might be useful in future choice of 
OA treatment strategies.  
A limitation of this human tissue-level study is that we could sample only at end 
stage KOA. Therefore, we are unable to comment on the relationship between 
disease initiation and MetS and its components. Based on the results of this study 
we can only speculate that targeted treatment of MetS would have a beneficial 
effect on OA and its symptoms. Also, our study is cross-sectional and we cannot 
offer conclusion if treatment of MetS abnormalities would act positively on BML 
resolution or progression of KOA. However, the study suggests that further 
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longitudinal research in a larger population would be beneficial to explore the 
interaction of metabolic mechanisms in the development of BMLs and OA 
pathogenesis. The current view is that biomechanical stress is the main causal 
factor of BML appearance in the tissue. Results from our study are incomplete as 
we only assessed BMI as an indicator of possible mechanical loading. However, 
the type and frequency of loading is important to take into consideration. 
Collecting high definition activity monitoring data, together with data on the 
metabolic status of the subject, would likely be favourable in terms of identifying 
links between these parameters and OA/BML development. 
In conclusion, our data suggest that a combination of specific metabolic factors 
might promote the occurrence of BMLs in tibial subchondral bone tissue and that 
metabolic factors might contribute to the progressive osteochondral degeneration 
of KOA. Larger longitudinal studies observing BML in individuals with MetS are 
needed to confirm whether treatment of MetS at an early stage of OA would be 
valuable for resolution of BML associated clinical symptoms and/or structural 
degeneration in KOA. 
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Table 4-3 Difference between patient characteristics among groups 
 
No BML BML p value BML 1 BML 2 p value 






Male [n (%)] 













BMI 33.7± 4.9 30.8± 4.9 0.04 30.5± 0.8 31.5±1 0.4 
K&L grade  2 (1-4) 3 (1-4) 0.7 2 (1-3) 3 (2-4) 0.04 
Cartilage Volume 
(mm3) 
1.30.2 1.00.3 0.01 1.10.3 0.80.3 0.006 
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Objective: It is not known how tissue level changes within bone marrow lesions 
(BMLs) relate to the microstructural changes across the human tibial plateau 
(TP). To address this, we evaluated subchondral bone microarchitecture, and 
cartilage deterioration, in non-osteoarthritis (OA) and in OA TP with and without 
BML.  
Design: Tibial plateaus were collected from 32 subjects, aged 49 to 79 years, 
undergoing total knee replacement surgery for knee OA (KOA), and from 12 non-
OA control subjects, aged 44 to 89 years. MRI was used to identify BMLs and to 
quantify cartilage volume. Micro CT was used to quantitate the subchondral plate 
and subchondral trabecular bone microstructure in seven volumes of interest; two 
oval cross-section cylinders representing the whole medial and lateral 
compartments; four circular cross-section cylinders representing anterior medial 
(AM), posterior medial (PM), anterior lateral (AL) and posterior lateral (PL) 
subregions of the compartments, and one cylinder representing BML. Cartilage 
loss and degeneration were evaluated by MRI measurement of cartilage volume 
and OARSI histological grading. 
Results: In non-OA control and OA-no BML groups, parameters describing 
subchondral bone (plate and trabeculae) showed no significant intragroup 
variability between compartments or subregions, while in OA-BML differences 
were evident. The anterior-medial region of OA-no BML did not differ significantly 
from non-OA controls. In contrast, the OA-BML group had significantly thicker 
subchondral plate (p=0.02, p=0.004), and trabeculae that are more numerous 
(p=0.03, p=0.03), well connected (p=0.009, p=0.003), and more plate-like 
(p=0.04, p=0.01), compared to both non-OA controls and OA-no BML. Cartilage 
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volume decreased and OARSI grade increased in OA-BML compared with 
controls, especially in the medial compartment. 
Conclusion: In established KOA, both the extent of cartilage damage and 
microstructural change in the subchondral bone depended on the presence of a 
BML. Thus, use of BMLs as MRI image-based biomarkers appears to inform on 
the severity of disease in established OA. 
 
Keywords; knee osteoarthritis, bone marrow lesions, subchondral bone 





5.1  Introduction 
Knee osteoarthritis (KOA) is a painful and degenerative musculoskeletal 
condition characterized by loss of osteochondral integrity. Specifically, 
destruction of cartilage (loss of cellular integrity and cartilage volume) and 
pathophysiological changes in the underlying subchondral bone, such as 
subchondral bone sclerosis, osteophytes, bone marrow lesions (BMLs) and bone 
cysts, are characteristics of advanced KOA. Although cartilage destruction has 
received the majority of research attention, there is evidence that changes in the 
subchondral bone may precede cartilage loss, and are thus important to 
understanding the pathogenesis and progression of OA [1-6]. 
Animal models of OA have described a predictable disease progression in OA, 
in which initial loss of subchondral bone is followed by sclerotic changes, 
increased anisotropy and an increase in the plate:rod ratio, prior to cartilage 
degeneration [7]. In human patients, since the majority of studies have described 
late stage OA, the sequence of KOA changes is less well understood.  
BMLs could assist in grading clinically important changes in the subchondral 
bone. BMLs are identified by magnetic resonance imaging (MRI), and are 
frequently seen in both early and late stage OA. They have acquired considerable 
clinical interest because their presence is predictive of degenerative changes in 
cartilage [8, 9] and future joint replacement [9]. Since BMLs can increase or 
decrease in size, and even resolve over time [10], the notion has developed that 
BMLs may have utility as biomarkers, both of disease progression and of 
response to treatment of KOA [11]. 
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Histologically, the subchondral bone contained within BMLs is described as 
sclerotic, with increased subchondral plate thickness, and trabeculae showing 
increased bone volume fraction, increased thickness, a more plate-like structure, 
and increased osteoid volume and thickness but reduced tissue mineral density 
[12-15]. Although these changes in subchondral bone have been reported as 
focal [12-15], the association between the presence of BMLs and the bone 
microstructure of the remainder of the tibial plateau has not been described.  
We hypothesized that the presence of a BML in KOA will associate with structural 
changes across the tibial plateau. Thus, the aim of this study was to 
comprehensively investigate and compare the subchondral bone 
microarchitecture of the whole tibial plateau in KOA subjects, with and without 
tibial BML, and in tibial plateau without OA. Specifically, the purpose of the study 
was to better understand tibial plateau regional subchondral bone changes in 
KOA and then to determine the association of the presence of a BML with the 
type and extent of bone changes. Finally, we determined the microstructural 
subchondral bone changes in relation to loss of cartilage integrity and volume. 
 
5.2 Materials and Methods 
5.2.1 Tibial plateau specimens 
Tibial plateaus were obtained from 32 patients, 20 females and 12 males aged 
49 to 79 years, undergoing knee arthroplasty surgery. Inclusion criteria were: 
radiographic OA with severe symptomatic disabilities, such as severe pain and 
limited mobility. Exclusion criteria were: KOA due to trauma or rheumatoid 
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arthritis, osteoporosis, and metabolic bone disease. Control tibial plateau 
specimens were obtained from 11 non-OA cadavers, 4 females and 7 males, 
aged 44 to 89 years with no previous history of bone or joint disease (eg. Paget’s 
disease, malignant tumors, avascular necrosis, rheumatoid arthritis), medication 
that may have affected bone metabolism, such as steroids and no macroscopic 
evidence of significant cartilage degeneration (all of the non-OA tibial plateau had 
Outerbridge score 0-1). Written consent was obtained for all subjects (joint 
replacement patients and cadavers) and the study received prior approval from 
the Human Research Ethics Committee at the Repatriation General Hospital, 
Royal Adelaide Hospital and The University of Adelaide, South Australia, in 
accordance with the Declaration of Helsinki 1975.  
 
5.2.2 Magnetic resonance imaging (MRI) 
Each tibial plateau was MR imaged ex vivo in an 8-channel wrist coil (3T MRI 
Siemens TRIO, Royal Adelaide Hospital, Adelaide), using two specific 
sequences; fat suppressed fast spin-echo proton density-weighted (PDFS) and 
T1 weighted spin echo in the sagittal and coronal plane. A BML was defined as 
a zone of altered signal intensity seen on PDFS +/- T1 weighted sequences in 
the bone and marrow (Figure 1A), located immediately beneath the articular 
cartilage and visible on at least two consecutive slices [15, 16]. The definition and 
location of BML were by mutual agreement between two investigators (AW and 
YW) with musculoskeletal MRI expertise. After identification of a BML, the 
external contour of the BML was marked in both planes and the automatic volume 
rendering function from OsiriX software (Pixmeo-SARL, Switzerland) was used 
to calculate the BML volume in cm3. The coefficient of variation for the 
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measurement of BML volume was 2.4%. Cartilage volume was assessed by two 
researchers (DM and YL), as described previously [15]. The coefficient of 
variation for the measurement of cartilage volume in the medial and lateral 
compartments was 2.2%.  
 
5.2.3 Micro CT 
To analyse the microstructure of the subchondral bone, whole tibial plateau was 
scanned by micro CT (SkyScan model 1076, Kontic, Belgium). Images were 
obtained at 74kV at isotropic resolution of 17.4 μm, with 1.0 mm aluminium filter 
and 0.8° rotation step. As depicted in Figure 1B, seven volumes of interest (VOI) 
were selected; two oval shapes to cover the whole medial (M; 45x25mm diameter 
x 6mm depth) and lateral (L; 40x25mm diameter x 6mm depth) compartments; 
four circular shapes (20mm diameter x 6mm depth) to cover the anterior medial 
(AM), posterior medial (PM), anterior lateral (AL) and posterior lateral (PL) 
subregions of the compartments; and one circular shape (10x10 diameter x 6mm 
depth) representing BML. The subchondral bone plate was manually segmented 
from the subchondral trabecular bone compartment for each VOI (Figure 1C). 
Subchondral plate and subchondral trabeculae were analyzed separately. Using 
CT-An analyzer software (SkyScan), the following morphometric parameters 
were determined for subchondral plate: plate thickness (Pl.Th) and plate porosity 
(Pl.Po) and for subchondral trabeculae: bone volume per total volume (BV/TV), 
trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation 
(Tb.Sp), structural model index (SMI) as measure of predominant shapes in the 
structure ( plate-like or rod-like), trabecular bone pattern factor (Tb.Pf) as 
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quantitative ratio of inter-trabecular connectivity, and degree of anisotropy (DA) 
which reflects the orientation of bone microarchitecture. 
 
5.2.4 Histopathology assessment 
Histopathological assessment was performed only for medial tibial plateau, as 
the majority of BML (75%) were detected in this compartment. Blocks of tissue 
(10x10x6mm) representing AM and PM (containing the entire BML, if present) 
were dissected using a low-speed diamond wheel saw (Model 660, South Bay 
Technology), formalin-fixed, decalcified in 5% hydrochloric acid, paraffin-
embedded, sectioned 5 μm-thick and stained with Safranin-O/Fast Green to be 
used for Osteoarthritis Research Society International (OARSI) grading [17]. 
Consensus between three assessors (DM, EG and YL) determined the grading. 
The intra-class correlation coefficient (ICC) for inter-observer reproducibility was 
0.82 (95% CI 0.80, 0.84).  
 
5.2.5 Statistical analysis  
All data sets were initially analysed by the Shapiro-Wilk test to determine 
normality of the data distribution. Parametric data are expressed as the mean ± 
standard deviation and non-parametric data as the median (25th-75th quartiles). 
The differences across groups for demographic variables, cartilage volume, 
histological grade, and subchondral bone plate and trabecular microstructure 
were investigated. For continuous normally-distributed variables a one-way 
ANOVA was used, for continuous non-normally distributed variables, a Kruskal-
Wallis test was used, and for categorical variables, a Fisher’s Exact test was 
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used. The critical value for statistical significance was chosen as P<0.05. These 
analyses were performed using the GraphPad Prism software (GraphPad 
Software, Inc., USA).  
Both adjusting for clustering on subject (multiple regions of interest) and 
controlling for the confounders age, sex and BMI and presence of BML, were 
performed in linear mixed-effects models. Linear mixed-effects models were also 
used to investigate the association between subchondral bone microstructural 
parameters versus cartilage volume, OARSI grade and BML volume. This was 
because there was clustering on patient ID and knee (multiple regions of interest 
in the same patient’s knee), which could be adjusted for by the use of a mixed-
effects model. Adjustment for multiple comparisons was made using a Sidak 
adjustment to account for significance of P values by chance due to large 
numbers of regressions being performed. These analyses were performed using 
statistical software SAS 9.4 (SAS Institute Inc., Cary, NC, USA). 
 
5.3 Results 
5.3.1 Demographic characteristics of the cohorts 
In the control group, only one subject was detected with a BML, which was 
located in the AL subregion. This case was excluded from further analysis. In OA 
subjects, BMLs were detected in 24 (75%) patients. The majority of BMLs were 
located in the medial compartment [18 out of 24 (75%)], with 12 (67%) located in 
the AM and 6 (33%) located in the PM. OA-BML subjects were predominantly 
diagnosed with medial OA (63%) and with varus malalignment (63%). The OA-
no BML subjects were a mix of all three compartmental OA types; Medial OA 
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(femoro-tibial compartment), Lateral OA (femoro-tibial compartment) and 
Patellofemoral OA, and had predominantly neutral alignment (62%).  
 
5.3.2 Cartilage volume and histological grading (intragroup variability)  
In controls and in OA-no BML, mean cartilage volumes measured over the whole 
M and L compartments were not significantly different between M vs. L 
compartments, while the L compartment of OA-BML had significantly thicker 
cartilage compared to M (p=0.0001). The mean OARSI grade was not different 
between AM and PM subregions in controls. In OA-no BML and OA-BML, the AM 
subregion had significantly higher mean OARSI grade compared to the PM 
subregion (p=0.001 and p=0.002 respectively, Figure 2B). 
 
5.3.3 Cartilage volume and histological grading between groups 
Mean cartilage volume in the M and L compartments was significantly lower in 
the OA-BML group compared to the M (p=0.0006) and L (p=0.002) of the control 
group. The mean cartilage volume of the OA-no BML group was intermediate 
between the control and OA-BML groups, and not significantly different from 
either group. In both OA-no BML and OA-BML groups, the AM subregion had 
significantly higher median OARSI grade than the control group (p=0.03 and 
p=0.0001, respectively). In the posterior medial subregion, the median OARSI 
grade was higher in OA-BML compared to both control (p=0.0001) and OA-no 
BML (p=0.03) groups (Figure 2B). 
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5.3.4 Microstructure of subchondral bone  
5.3.4.1 Subchondral bone plate characteristics (intragroup variability)  
In controls and in OA-no BML, mean plate thickness did not differ significantly 
between M vs. L compartments, nor between AM vs. PM and AL vs. PL 
subregions. In OA-BML, mean plate thickness was significantly greater in AM vs. 
AL and vs. PL (p=0.0001, 0.002) and in PM vs. AL and vs. PL (p=0.02 and 
p=0.0005). No difference was observed in mean plate porosity between regions 
in all groups. Results are presented in Figure 3A. 
 
5.3.4.2 Subchondral bone plate microstructure between groups  
Differences in subchondral plate microstructure between groups for each region 
of interest are presented in Figure 3B. 
 
Medial compartment 
The OA-no BML group had decreased median plate thickness compared to OA-
BML (p=0.02) and controls (p=0.03). The OA-BML group had increased median 
plate porosity compared to controls (p=0.02). 
 
Anterior medial subregion  
The OA-BML group had increased mean plate thickness compared to controls 
and OA-no BML (p=0.04, p=0.004, respectively), and increased mean plate 





Posterior medial subregion 
The OA-BML group had increased mean plate thickness and porosity compared 




Median plate thickness was greater in controls for the L compartment, compared 
with OA-no BML and OA-BML groups. No significant difference was observed in 
median plate porosity parameters between the three groups in the L, AL or PL.  
 
5.3.4.3 Subchondral trabecular bone microstructure (intragroup variability)  
As seen for the subchondral plate, parameters describing subchondral trabecular 
bone microstructure of non-OA controls and OA-no BML showed no significant 
intragroup variability between compartments or subregions. However, in OA-
BML, differences were evident. These results are presented in Figure 4. 
 
Percent bone volume (BV/TV) 
In OA-BML, mean BV/TV was significantly higher in M vs. L (p=0.03), in AM vs. 
PM (p=0.03), vs. AL (p=0.03) and vs. PL (p=0.03). 
 
Trabecular number (Tb.N) 
In OA-BML, mean Tb.N was significantly higher in the AM vs. PM (p=0.04), vs. 
AL (p=0.04), and vs. PL (p=0.04). 
 
Trabecular thickness (Tb.Th) 
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In OA-BML, mean Tb.Th was significantly higher in M vs. L (p=0.003), in AM vs 
AL (p=0.001) and in PM vs AL (p=0.0003) and vs. PL (p=0.03). 
 
Trabecular separation (Tb.Sp) 
Trabecular separation did not differ significantly between compartments and 
subregions in any group. 
 
Structure model index (SMI) 
In OA-BML, mean SMI was significantly lower, indicating more plate-like 
trabeculae, in M vs. L (p<0.0001), in AM vs. PM, vs. AL, vs. PL and (p=0.0005, 
p<0.0001, p<0.0001, respectively) and in PM vs.AL (p=0.001) and vs. PL 
(p=0.04). 
 
Degree of anisotropy (DA) 
In OA-BML, median DA was significantly higher in M vs. L (p=0.02), in AM vs. AL 
(p=0.01), and vs. PL (p<0.0001), and in PM vs.PL (p=0.002). 
 
Trabecular pattern factor (Tb.Pf)  
In OA-BML, mean Tb.Pf was significantly decreased in M vs. L (p=0.0008), and 
in AM vs. PM, vs. AL and vs. PL (p=0.002, p<0.0001 and p<0.0001, respectively) 
and in PM vs. AL (p<0.0001). 
 
5.3.4.4 Trabecular bone microstructure differences between groups  




M compartment of OA-no BML was similar to controls except that it showed 
higher mean DA (p= 0.03). Compared to the control group, OA-BML had 
significantly higher mean Tb.Sp (p=0.01), and DA (p=0.0002) and lower median 
Tb.Pf (p=0.005). Compared to OA-no BML, OA-BML had higher mean BV/TV 
(p=0.008), Tb.N (p=0.01), lower mean SMI (p=0.0004) and lower median Tb.Pf 
(p=0.0002) in the medial compartment.  
Anterior medial subregion 
The AM subregion of OA-no BML was similar to controls except that it showed 
higher median DA (p= 0.03). OA-BML had significantly higher mean Tb.N 
(p=0.03), Tb.Sp (p=0.01) and median DA (p<0.0001) and lower mean SMI 
(p=0.04), and median Tb.Pf (p=0.003), compared to controls. OA-BML compared 
to OA-no BML, had higher mean BV/TV (p=0.02) and Tb.N (p=0.03), but lower 
mean SMI (p=0.01) and median Tb.Pf (p=0.02). 
Posterior medial subregion 
In the PM, OA-no BML had higher mean SMI (p=0.004) and median Tb.Pf 
(p=0.006) compared to controls. OA-BML had higher mean Tb.Th (p=0.02) and 
median DA (p=0.001) compared to controls. Comparing OA-BML to OA-no BML, 
OA-BML had higher mean BV/TV (p=0.03) and lower mean SMI (p=0.01) and 
median Tb.Pf (p=0.01). 
Lateral compartment 
Both OA-no BML and OA-BML had higher mean SMI (p=0.003, p<0.0001, 
respectively) and median Tb.Pf (p=0.01, p<0.0001, respectively), compared to 
controls. No differences were found between OA-no BML and OA-BML. 
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Anterior lateral subregion  
No differences were found between OA-no BML vs. control or between OA-no 
BML vs. OA-BML. OA-BML had lower median Tb.Sp (p=0.04) and higher median 
Tb.Pf (p=0.005), compared to controls. 
Posterior lateral subregion 
The OA-BML group showed higher median Tb.Pf (p=0.005) than controls. No 
other group differences were observed for the PL parameters between OA-no 
BML vs. control, or between OA-BML vs. OA-no BML. 
 
5.3.5 Correlation between subchondral bone microstructural parameters, 
histological OARSI grade, cartilage volume and BML volume. 
Correlation analyses were performed between parameters describing 
subchondral bone microstructure and cartilage volume, obtained from the medial 
and lateral tibial compartments, and between subchondral bone microstructure 
and OARSI grade obtained from the anterior medial subregions. In the medial 
compartment of OA-no BML, Tb.N (r=-0.65, p=0.04) correlated negatively, and 
Tb.Sp (r=0.77, p=0.02) positively, with cartilage volume. In the anterior medial 
subregion of OA-no BML, Tb.Th (r=0.78, p=0.02) correlated positively, and DA 
(r=-0.85, p=0.01) negatively, with OARSI grade.  
In the medial compartment of the OA-BML group, Tb.N (r=-0.67, p=0.003) and 
Tb.Th (r=-0.57, p=0.04) correlated negatively with cartilage volume. In the 
anterior medial subregion of OA-BML, Pl.Th (r=0.76, p=0.01), BV/TV (r=0.65, 
p=0.01) and Tb.N (r=0.54, p=0.04) correlated positively with OARSI grade, while 
Tb.Sp (r=-0.64, p=0.01) and SMI (r=-0.61 p=0.02) correlated negatively with 
OARSI grade.  
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In the lateral compartment of the control, OA-no BML and OA-BML groups, no 
correlations were observed between parameters of subchondral bone 
microstructure cartilage volume and OARSI grade. 
Correlation analyses were performed between microstructural parameters of 
anterior medial and posterior medial subregions in OA-no BML and OA-BML. In 
OA-BML, no significant correlation was found. In OA-BML, changes in 
microstructural parameters of the anterior medial subregion correlated positively 
with changes in the posterior medial subregion; BV/TV (r=0.64, p=0.01), Tb.Th 
(r=0.78, p=0.001), Tb.N (r=0.69, p=0.008). 
Correlation analyses between BML volume and microstructural parameters of the 
whole medial compartment, and the posterior medial subregion, indicated 
positive association in both for BVTV (r=0.48, p=0.04 and r=0.51, p=0.04) and 
Tb.N (r=0.53, p=0.02 and r=0.62, p=0.01), respectively. 
 
5.4 Discussion 
To our knowledge, this is the first comprehensive study of the subchondral bone 
microstructure (subchondral plate and trabeculae) across the whole OA tibial 
plateau in association with presence/absence of BMLs. In this study, there were 
three major findings relating to the subchondral bone microarchitecture of the 
tibial plateau due to KOA. Firstly, similarly as in non-OA (control) subjects, in OA 
subjects with no BML, bone microstructure of the subchondral plate and 
trabeculae did not vary significantly between subregions of the tibial plateau, 
while in OA subjects with detectable tibial BML, differences in microstructure 
between subregions were evident. Secondly, in KOA subjects, microstructural 
changes in the subchondral plate and trabeculae were dependent on the 
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presence or absence of a BML in the tibial plateau, which also related to the 
extent of cartilage degradation. Thirdly, the microstructural changes within a BML 
often extended well beyond the zone of the BML. These observations suggest 
that BMLs derived from MRI clinical imaging might serve as an indicative tool of 
OA severity at the tissue level. 
5.4.1 Structural changes in the subchondral bone plate and trabeculae in 
KOA subjects 
The subchondral bone comprises the subchondral plate and the trabeculae. The 
architectural, biological and biomechanical properties of these two units are 
different and respond differently during OA progression. The present study 
demonstrates that subregional differences in control group and OA-No BML were 
not significant. In comparison, in the OA-BML group, substantial differences in 
bone microstructure were found between regions.  
Consistent with previous studies of the human tibial plateau, we observed that 
changes of subchondral bone microstructure of the OA-BML group were more 
pronounced in the medial compartment than in the lateral compartment. 
Furthermore, and again similar to previous studies, significant differences 
between the anterior and posterior regions of these compartments were found 
[18-20]. The most substantial microstructural changes were found in the AM 
subregion of OA-BML, where the majority of BMLs were found (75%). In the OA-
BML group, the AM subregion did not differ in plate characteristics to the PM 
region. However, trabecular bone of the AM region showed more prominent 
sclerotic changes, such as higher bone volume, and more numerous and plate-
like trabeculae compared to PM. Comparing the AM subregion to AL and PL, 
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significant differences were found in all parameters describing the microstructure 
of the subchondral plate and trabeculae.  
Cox et al. described asymmetric loading between medial and lateral 
compartments of the knee that might contribute to development of OA [21]. 
Recently, Roberts et al. suggested that joint alignment influences both medial to 
lateral and within-condyle distribution of forces across the tibia that results in 
changes of subchondral bone microstructure, at least in late stage OA. They 
further showed that regional variation in bone microstructure within tibial 
compartments likely reflects joint loading history in KOA [22]. In a separate study, 
the same group identified three subgroups in KOA patients, based on distinct 
walking gait patterns, suggesting that there might be different mechanisms for 
generating loads through the tibial plateau, with corresponding microarchitectural 
adaptation [23]. With respect to BMLs, high peak knee adduction moment and 
high knee adduction moment impulse, as well as static alignment were 
significantly related to the presence of BMLs [24]. Lim et al., demonstrated from 
a systematic review of the literature, a strong relationship between meniscal 
pathology and mechanical knee alignment and BML in the OA population. 
Interestingly, the same review suggested that there is no strong association 
between BML presence and physical activity [25]. The conclusion was that BML 
areas represent a “hot spot” in the tibial plateau where changes in the bone 
microstructure might be the result of an acute localised tissue response as well 
as a pathophysiological interaction between the bone and cartilage [1, 26]. 
When we compared microstructural parameters between groups, we found 
substantial thinning of the subchondral plate in the medial compartment of OA-
no BML, compared to both control and OA-BML. In contrast, the subchondral 
plate of OA-BML was thicker in the AM and PM subregions compared to the same 
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subregions of both control and OA-no BML groups. We also found an increased 
porosity of the subchondral plate in OA-BML compared to controls, likely 
reflecting altered vascularity and/or bone resorption within the subchondral plate. 
The increased porosity could also affect the permeability of the osteochondral 
interface and play a direct role in the pathogenesis of OA. Increasing porosity of 
the subchondral plate was observed to co-localise with the point of mechanical 
load during ambulation in a rat knee model of post-traumatic OA [27]. 
Trabecular bone of medial compartment or its anterior aspect did not differ 
significantly between OA-no BML and controls beside higher degree of 
anisotropy in the medial compartment, indicating that OA-no BML has more 
preferential trabecular alignment compared to controls. In the PM subregion, OA-
no BML had higher mean values for SMI and Tb.Pf compared to controls, 
indicating persistence of a rod-like structure with low connectivity. Furthermore, 
we found that trabecular bone in the AM subregion of OA-no BML, compared to 
the same region of OA-BML, was characterised predominantly with lower bone 
volume and fewer trabeculae that are more rod-like (indicated by increased SMI). 
While the PM subregion of OA-no BML had lower mean bone volume, more rod-
like trabeculae that were more isolated or less connected (indicated by larger 
Tb.Pf), compared to PM of OA-BML. 
The thinning of the subchondral plate and the reduced number of trabeculae both 
suggest a process of bone attrition at some prior stage of the disease 
progression. In addition, recently it has been suggested that rod-like structure 
(indicated by increased SMI) might have a protective effect on cartilage during 
impact loading [28, 29]. However, in a separate study it has been noted that SMI 
alone may not be the optimal parameter to make assessment of rod-like and/or 
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plate-like structure [30]). Further clarification and definition of the microstructural 
parameters representing rod-like and/or plate-like structure is needed. 
Previously, similar findings (to OA-no BML) were only reported in animal models 
such as in the Duncan Hartley guinea pig model of OA, when an early change 
was described by thickening of the subchondral plate and trabeculae, but the 
subchondral bone was found to change across time, eventually resembling that 
of a non-OA guinea pig strain [31]. Also, these alterations in animal bone structure 
have been found to precede severe cartilage degeneration and to associate with 
histopathological changes in the cartilage [3-5]. 
Recently, Chen et. al. demonstrated a novel finding in microstructural adaption 
due to OA disease, in terms of significant loss of rod-like trabeculae and 
thickening plate-like trabeculae in all regions of the human tibial plateau (with and 
without severe cartilage loss) providing a valuable insight into the dynamics of 
subchondral bone microstructural changes in OA. They also confirmed that 
similar changes preceded cartilage degeneration in the guinea pig model of 
spontaneous OA. These results suggested that specific trabecular changes might 
be important during the development and progression of OA [32]. 
Complementary to those findings, in our study SMI, DA and Tb.Pf, as nonmetric 
measures of topological structural features and useful determinants of 
mechanical strength [33], were significantly different in both OA-no BML and OA-
BML compared to controls, confirming a lower bone quality of OA subchondral 
bone and its inability to resist overloading [34]. 
Collectively, structural alterations found in OA-no BML resemble changes that 
have been described previously as early OA [3-5, 35-42]. The OA BML group 
was associated with the greatest degree of sclerotic microstructural changes, 
 150 
cartilage degeneration and loss of cartilage volume, consistent with late stage 
OA [19, 20, 43].  
5.4.2 Presence of BMLs predicts wider microstructural changes in the 
tibial plateau  
The presence and size of BMLs is strongly associated with clinical symptoms 
(pain) [44] and focal structural degeneration (loss of cartilage and bone sclerosis) 
[12-15]. The present results suggest that the presence of a BML might be 
associated with structural changes beyond the BML, particularly in the medial 
compartment. Moreover, it seems that focal sclerosis of the BML area expands 
radially to the adjacent subregions (Figure 7). As BML sclerotic changes in a 
specific compartment are closely related to loss of cartilage volume and higher 
OARSI grade in the same compartment, BMLs could represent an epicentre of 
the structural change in the OCU of the tibial plateau. Interestingly, these data 
suggest that the MRI signal that represents a BML is not due to bone changes, 
and more likely resides in the inter-trabecular marrow. 
Sclerotic changes are widely accepted as a key feature of advanced OA 
progression, but it is important to point out that these findings have not been 
consistently reported for end stage OA [45, 46]. A possible explanation for the 
different observations between studies might be due to the presence or absence 
of BMLs, since these subchondral bone features appear to segregate with more 
severe disease. Recently, Steinbeck et al. described two subtypes within a KOA 
population, defined according to microstructural features of subchondral bone 
(sclerotic and non-sclerotic trabecular bone), and suggested different 
mechanisms of disease progression [47]. Finnila et al. also analysed the tibial 
plateau in late stage of OA and found that bone volume fraction, trabecular 
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thickness and trabecular number increase with OARSI grade, while trabecular 
separation and structure model index decrease, suggesting that sclerosis might 
potentially be used in radiological assessment of OA severity [48]. Neither of 
these studies considered the presence or absence of a BML in the tissue. Our 
study suggests that OA subjects without a BML belong to a non-sclerotic OA 
subtype, while those with BML belong to a sclerotic OA subtype. This conclusion 
will require greater numbers for confirmation.  
Our study has several limitations. Firstly, the relatively small and heterogeneous 
OA-no BML group limits the strength of comparisons with other groups to 
investigate in more detail the relationship between BML and subchondral bone 
structure. Further studies are recommended to investigate these relationships. 
Secondly, as this study is cross-sectional in design, the changes in subchondral 
bone structure characteristic of early stage disease cannot be confirmed, nor can 
mechanisms of BML genesis in the tissue be identified. Longitudinal studies 
would help to clarify this sequence of events. We believe the strength of this study 
is that we have analysed subchondral bone microstructure for the entire human 
tibial plateau, while previous studies have mainly investigated bone 
microstructural changes in specific sub-regions.  
5.4.3 Conclusion 
Study of the microstructure of tibial plateaus in KOA showed that the presence of 
a BML defines the changes in both the subchondral bone and cartilage, which in 
turn relate to the severity of the disease. BMLs may therefore provide surrogate 
biomarkers that can discriminate OA subtypes or severity, for example helping to 
triage candidates for joint replacement surgery or conservative, non-surgical 
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Figure 5-1 Representative cross-section images A) MRI of tibial plateau 
(upper-transaxial, lower-coronal, right-sagittal views) with BML (pink area 
enclosed by red dashed line) detected by PDFS+T1 weighted sequences. 
B) Micro CT of whole tibial plateau (upper-transaxial, lower-coronal, right-
sagittal views), regions of interest M-medial (blue oval shape), AM-anterior 
medial (dark green round shape), PM-posterior medial (light green round 
shape), location of BML region of interest was determined using MRI 
coordinates. C) Coronal view of AM subregions from control, OA-no BML 
and OA-BML. Subchondral plate (yellow) was manually selected to obtain 




Figure 5-2 A). Cartilage volume and OARSI grade (Intragroup variability; B). 
Cartilage volume and OARSI grade between groups. 
*p<0.05, **p<0.005, ***p<0.0005, **** p<0.0001 
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Figure 5-3 A). Intragroup variability; B). Subchondral bone plate 
microstructure between groups. 
*p<0.05, **p<0.005, ***p<0.0005, **** p<0.0001.  
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Figure 5-4 Parameters describing trabecular bone microstructure of medial 
and lateral compartments and its anterior and posterior subregions in 
Controls, OA-no BML and OA-BML groups. 
*p<0.05, **p<0.005, ***p<0.0005, **** p<0.0001.  
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Figure 5-5 Subchondral trabecular bone microstructure between groups in 
medial compartment, anterior medial and posterior medial subregion. 




Figure 5-6 Subchondral trabecular bone microstructure between groups in 
lateral compartment, anterior lateral and posterior latera.  
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Figure 5-7 Representative image of subchondral trabeculae in the medial 
compartment (transaxial view) of control, OA-no BML and BML groups. In 
OA-BML, approximate location of BML is shown by a red circular shape, 
AM-anterior medial (dark green round shape), PM-posterior medial (light 
green round shape). Purple solid line showing extent of sclerotic 














6.1 General discussion 
Osteoarthritis (OA) is a slow multifactorial disease affecting the whole joint, with 
the most prominent degenerative changes occurring within the osteochondral unit 
(OCU). Despite the great endeavour of the OA research society to discover the 
early initiating events in OA, the pathogenesis of OA remains as an enigma. One 
of the main reasons for this is that human OA is mostly diagnosed at an advanced 
stage, when significant loss of cartilage volume has already taken place. With the 
evolution of high resolution imaging modalities, especially MRI, there is 
increasing ability to observe longitudinal structural changes in OA, such as 
cartilage damage and loss of cartilage volume, narrowing of joint space and 
pathological changes in subchondral bone.  
Bone marrow lesions (BMLs), which are uniquely identified by MRI as signal 
changes of subchondral bone, became features of OA research interest when 
significant association between BML presence and loss of cartilage and clinical 
symptoms was found [1-6]. Since then, several large clinical studies have 
established the close relationship between BMLs and initiation, progression and 
potential outcome in human knee osteoarthritis (KOA), [7-9]. However, what MRI-
identified BMLs represent at the tissue level, and what are the mechanisms 
behind the appearance of BMLs in subchondral bone tissue, remains unknown. 
The tissue level studies in this thesis were designed to address these questions 
and to test the hypothesis that the presence of BMLs in human proximal tibial 
OCU is indicative of the progression of OA disease.  
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6.2 Overview of study findings 
In the first study described in the thesis (Chapter 2), a multi-modal tissue level 
analysis of the entire OCU- cartilage, subchondral bone (subchondral plate and 
trabeculae) and bone marrow- revealed that an OCU containing a detectable 
BML was characterised by more degenerative changes, such as lower volume of 
the cartilage, higher OARSI histological grade, thicker subchondral bone plate, 
increased trabecular bone volume, increased plate-like and decreased rod-like 
trabecular structures, increased osteoid volume, and increased bone marrow 
oedema, fibrosis fibrovascular cysts and fat tissue necrosis, compared to OCU 
without BML. Furthermore, the extent of structural changes in a tibial plateau 
containing a BML was different dependent on the subtype of BML detected by 
particular MRI sequences. BMLs detected by both PDFS and T1 sequences 
(BML 2) were characterised as lesions having the most advanced degenerative 
changes throughout the whole OCU, compared with BMLs detected only by 
PDFS sequences (BML 1). These data suggest that assessment of BMLs using 
specific MRI sequences might help to further differentiate the degree of tissue 
degeneration in the OCU. Although these two sequences are most commonly 
used to assess bone and cartilage changes in KOA, the relationship of the 
specific sequences to the extent of these OCU changes has not previously been 
appreciated. Concurrent with this study, a clinical study reported that BML 2 was 
associated with greater cartilage volume loss and pain than BML1 [10], results 
consistent with and broadly supportive of the findings described in Chapter 2. 
Importantly, the data from this study indicate that BML 1 may identify OA that has 
retained the ability to respond to treatment. 
After characterising BMLs at the tissue level, the thesis next explored the 
potential mechanisms, by which BMLs may develop in the tissue. Previously, it 
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has been suggested that the potential mechanism behind BML appearance in 
tissue might involve mechanical, metabolic and vascular factors. Thus, in Chapter 
3, tissue-level evidence of mechanical and vascular influence in BML 
development was sought.  
This study found an increased burden of microdamage to the bone matrix, and 
increased osteocyte density, in both the subchondral bone plate and subchondral 
trabeculae of BML areas. These findings provide tissue level evidence of the 
involvement of biomechanical factors, in particular increased mechanical loading, 
underlying the formation of BMLs. Furthermore, altered vascular characteristics 
were observed, i.e. increased arteriolar wall thickness and wall:lumen ratio, in 
regions within BMLs compared to no BML regions, which was in addition to the 
findings described in Chapter 2 of increased thick-walled arteriolar density and 
number of small fibrovascular cystic formations. Together, these data provide 
significant evidence for a vascular contribution to BML formation. 
The changes in vascular wall parameters provoked further interest to explore the 
potential relationship between metabolic influences, such as hypertension, and 
the presence of BMLs. Components of the metabolic syndrome (MetS) have 
previously been linked the development and/or progression of KOA, making it 
reasonable to investigate their possible role in BML formation. In the work of 
Chapter 4, an increased prevalence of MetS, defined as a cluster of three or more 
metabolic disorders [11], was found in OA subjects with BMLs compared to OA 
subjects without a BML. It was also found that high total cholesterol and high BMI 
showed significant association with higher radiographic score (higher KL grade 
and loss of cartilage volume), which may indicate that metabolic factors could link 
to the progression of KOA. Further, high fasting glucose and triglyceride levels 
were significantly associated with larger BML volume size and could be factors 
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that directly associate with BML aetiology. Taken together, these results suggest 
that metabolic factors may have a possible contributing role in the development 
and/or progression of BMLs in KOA. 
Finally, in Chapter 5 a comprehensive investigation of the regional changes in 
subchondral bone microarchitecture of whole tibial plateau was undertaken with 
the aim of elucidating how the presence of a BML might affect microstructural 
changes across the whole tibial plateau. This study revealed that in OA subjects 
with no BML, bone microstructure of the subchondral plate and trabeculae did 
not vary significantly between subregions of the tibial plateau, while in OA 
subjects with BML, significant differences in microstructure between tibial 
subregions were evident. Microstructural changes in the subchondral bone were 
also closely correlated to the extent of cartilage degradation. The data suggest 
that areas of BML subchondral bone, previously described as focal sclerotic 
bone, might actually represent an area of the bone where microstructural 
changes start and then expand beyond the BML signal margins seen on MRI. 
These observations again linked the presence of a BML to OA severity. 
 
6.3 Strengths and limitations 
The strength of these studies is that the sample size use to describe the 
characteristics of BMLs at the tissue level was the largest compared to those 
previously published. These investigations are also the first to use two specific 
clinically approved and commonly used MRI sequences to detect BMLs in human 
tibial plateau tissue and (a) to explore how the presence of a BML relates to the 
changes in each component of the OCU (cartilage, subchondral bone and bone 
marrow) and (b) how the two BML subtypes can differentiate the extent of tissue 
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degeneration. This work has made an important contribution to a better 
understanding of the role of subchondral bone in the progression of OA. 
A limitation of the studies is that all samples obtained are by definition at ‘end-
stage’ disease (joint replacement surgery) and the data collected are cross-
sectional, rather than longitudinal. As such, it was not possible to establish 
definitively the relationship between findings and proposed mechanisms. In order 
to definitively establish the novel relationships suggested from this thesis, further 
studies using larger numbers across different age groups and longitudinal in 
nature should be undertaken. Examination of larger cohorts in the future will allow 
confirmation of the categorisation of the BML and/or OA into identifiable 
subtypes, suggested by the current findings. This in turn then might allow more 
individualised approaches to treatment and management of OA patients.  
A second limitation is that only knee OA was studied and findings might differ for 
other skeletal joints. For example, do BMLs in different joints represent the same 
pathological changes at the tissue level as in the knee? Therefore, skeletal sites 
other than the widely-studied knee (eg. hip, hand, spine etc.) are important for 
further investigation.  
Commonly, human joint tissue is available only upon joint replacement and 
therefore represents end stage disease and usually older individuals. Thus, in 
order to discover the potential usefulness of BMLs more dynamically and their 
involvement in OA progression over time, additional approaches are needed. 
These might include animal models or even biopsies taken from joint tissue 
before any sign of OA and during the course of OA development. Recently, a 
rabbit model has been developed to explore the direct relationship between 
mechanical loading and the presence of BMLs [12]. However, this study included 
a small sample number (n=3) and did not explore any other potential mechanisms 
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(vascular or metabolic) or influences on the initiation or progression of BMLs. This 
type of preclinical study might be useful in more comprehensive exploration of 
BMLs in OA. 
 
6.4 Areas for further research 
In this thesis BML signals detected by MRI have been found to strongly associate 
with progressive structural changes in the whole OCU. Unfortunately, it has not 
been possible to directly correlate the signal with specific tissue pathological 
change. However, the data are consistent with the notion that signals originate 
from the bone marrow. But, to gain more knowledge about BMLs as therapeutic 
targets there is need to precisely define the origin of the BML-MRI signal (bone 
marrow, subchondral bone or combination of both). A next step to confirming this 
might be to remove the marrow from bone containing a BML and subject it again 
to MRI. In addition, very little is known about changes in BML regions at the 
cellular level and what molecules regulate those changes. Thus, one next step in 
BML research will be to investigate and define the specific molecular signature of 
BMLs. 
Recently in a pilot project (see Appendix), we used a powerful spatial proteomic 
technology named matrix-assisted laser desorption/ionisation imaging mass 
spectrometry (MALDI-IMS) that allowed us to collect a large amount of molecular 
information directly from bone tissue sections [13]. Interestingly, we found that 
BML regions of tibial plateau had a prominent N-linked glycan signal. Protein 
glycosylation is one of the important processes in many regulatory mechanisms 
and its alteration has been found to be in close association with ischemia, 
vascular dysfunction and cellular oxidative stress mechanisms that have 
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previously been indirectly associated with the presence of BMLs in the tissue [14]. 
Thus, further exploration and application of this method has high potential to 
reveal the molecular signature of BMLs and to provide unique insight into 
molecular regulation and aetiology of BMLs. Furthermore, this technique may 
directly aid in identifying differences in molecular profiles between BMLs detected 
by specific MRI sequences (BML1, BML 2).  
The studies presented in this thesis support the growing concept that changes in 
the subchondral bone may be a key feature in the progression of the OA. 
Therefore, therapies targeting bone quality might be beneficial. Recently, the 
technique named Raman spectroscopy has been used to detect the overall 
biochemical signature of the bone, and clear differences were found between OA 
and non OA subchondral bone. Likewise, at the protein level, it was found that 
the ratio of 1:2 chains of Type 1 collagen was significantly changed in OA 
subchondral bone compared to non-OA bone of the knee [15]. Similar changes 
were found in the hip [16]. However, to this date there is no study exploring these 
bone matrix changes in BML. It would be of considerable interest to investigate 
changes of bone matrix between OA bone with and without BML as the findings 
may help to facilitate the identification of disease processes at early/late stage 
and/or to identify changes that are specific for OA subtypes (OA-BML, OA-No 
BML). 
 
6.5 Conclusions  
The comprehensive tissue level analyses described in this thesis highlight that 
the changes in the whole OCU are important for the assessment of OA 
progression. BMLs are valuable MRI biomarkers with large potential to follow the 
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progression of OA disease and changes in the whole OCU. Furthermore, BML 
are indicative of an active tissue response to OA disease and could assist in 
future identification of specific subtypes in human OA. 
Thus, BMLs have the potential to be used as tools for monitoring the efficiency 
of new therapies and the development of more individual approaches of, and for 
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Chapter 7 APPENDIX 
MALDI Mass Spectrometry Imaging of N-Glycans on Tibial 
Cartilage and Subchondral Bone Proteins in Knee 
Osteoarthritis 
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